• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Assessing patients' satisfaction with anti-TNFα treatment in Crohn's disease: qualitative steps of the development of a new questionnaire.评估克罗恩病患者对抗肿瘤坏死因子α治疗的满意度:一份新问卷开发的定性步骤
Clin Exp Gastroenterol. 2011;4:173-80. doi: 10.2147/CEG.S18585. Epub 2011 Jul 27.
2
Measuring patients' satisfaction with their anti-TNF treatment in severe Crohn's disease: scoring and psychometric validation of the Satisfaction for PAtients in Crohn's diseasE Questionnaire (SPACE-Q(©)).评估重症克罗恩病患者对其抗TNF治疗的满意度:克罗恩病患者满意度问卷(SPACE-Q(©))的评分及心理测量学验证
Patient Prefer Adherence. 2014 Dec 4;8:1671-81. doi: 10.2147/PPA.S72004. eCollection 2014.
3
Motivation to pursue anti-TNFα treatment in patients with Crohn's disease - the SPACE motivation study.追求抗 TNF-α 治疗的动机 - SPACE 动机研究。
Dig Liver Dis. 2020 Sep;52(9):995-1001. doi: 10.1016/j.dld.2020.05.032. Epub 2020 Jun 10.
4
Validation of the treatment satisfaction questionnaire for Crohn's disease (TSQ-C).克罗恩病治疗满意度问卷(TSQ-C)的验证
Dig Dis Sci. 2005 Feb;50(2):252-8. doi: 10.1007/s10620-005-1591-3.
5
Multinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: the 'Perception of Anticoagulant Treatment Questionnaire' (PACT-Q).评估患者对抗凝治疗满意度的问卷的跨国开发:“抗凝治疗认知问卷”(PACT-Q)。
Health Qual Life Outcomes. 2009 Feb 6;7:9. doi: 10.1186/1477-7525-7-9.
6
Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.英夫利昔单抗和其他抗肿瘤坏死因子 α 治疗药物治疗炎症性肠病。
BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000.
7
Scoring and psychometric properties of the Eye-Drop Satisfaction Questionnaire (EDSQ), an instrument to assess satisfaction and compliance with glaucoma treatment.《眼药满意度问卷》(EDSQ)的评分和心理测量学特性,该工具用于评估青光眼治疗的满意度和依从性。
BMC Ophthalmol. 2010 Feb 1;10:1. doi: 10.1186/1471-2415-10-1.
8
Assessing quality of life in Crohn's disease: development and validation of the Crohn's Life Impact Questionnaire (CLIQ).评估克罗恩病患者的生活质量:克罗恩病生活影响问卷(CLIQ)的编制与验证
Qual Life Res. 2015 Sep;24(9):2279-88. doi: 10.1007/s11136-015-0947-1. Epub 2015 Feb 22.
9
Long-term treatment acceptance: what is it, and how can it be assessed?长期治疗接受度:是什么,如何评估?
Patient. 2012;5(4):239-49. doi: 10.2165/11631340-000000000-00000.
10
Development and initial psychometric validation of a patient-reported outcome measure for Crohn's perianal fistula: the Crohn's Anal Fistula Quality of Life (CAF-QoL) scale.开发并初步验证一种用于评估克罗恩病肛周瘘的患者报告结局测量工具:克罗恩病肛周瘘生活质量量表(CAF-QoL)。
Gut. 2021 Sep;70(9):1649-1656. doi: 10.1136/gutjnl-2019-320553. Epub 2020 Dec 3.

引用本文的文献

1
Patient-reported outcome measures for medication treatment satisfaction: a systematic review of measure development and measurement properties.患者报告的药物治疗满意度测量指标:测量开发和测量特性的系统评价。
BMC Med. 2024 Sep 2;22(1):347. doi: 10.1186/s12916-024-03560-3.
2
Measuring patients' satisfaction with their anti-TNF treatment in severe Crohn's disease: scoring and psychometric validation of the Satisfaction for PAtients in Crohn's diseasE Questionnaire (SPACE-Q(©)).评估重症克罗恩病患者对其抗TNF治疗的满意度:克罗恩病患者满意度问卷(SPACE-Q(©))的评分及心理测量学验证
Patient Prefer Adherence. 2014 Dec 4;8:1671-81. doi: 10.2147/PPA.S72004. eCollection 2014.

本文引用的文献

1
Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial.切换至阿达木单抗治疗维持缓解的英夫利昔单抗治疗克罗恩病患者:前瞻性随机 SWITCH 试验。
Gut. 2012 Feb;61(2):229-34. doi: 10.1136/gutjnl-2011-300755. Epub 2011 Sep 23.
2
The diagnosis and treatment of Crohn's disease and ulcerative colitis.克罗恩病和溃疡性结肠炎的诊断与治疗。
Dtsch Arztebl Int. 2009 Feb;106(8):123-33. doi: 10.3238/arztebl.2009.0123. Epub 2009 Feb 20.
3
Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn's disease.加拿大胃肠病学协会临床实践指南:肿瘤坏死因子-α拮抗剂疗法在克罗恩病中的应用
Can J Gastroenterol. 2009 Mar;23(3):185-202. doi: 10.1155/2009/201430.
4
Patient's perspectives important for early anti-tumor necrosis factor treatment in inflammatory bowel disease.患者观点对于炎症性肠病早期抗肿瘤坏死因子治疗很重要。
Digestion. 2009;79(1):30-5. doi: 10.1159/000203638. Epub 2009 Feb 25.
5
Guideline adherence and patient satisfaction in the treatment of inflammatory bowel disorders--an evaluation study.炎症性肠病治疗中的指南遵循情况与患者满意度——一项评估研究
BMC Health Serv Res. 2009 Jan 27;9:17. doi: 10.1186/1472-6963-9-17.
6
Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.阿达木单抗维持治疗对克罗恩病患者健康相关生活质量的影响:CHARM试验的患者报告结局
Am J Gastroenterol. 2008 Dec;103(12):3132-41. doi: 10.1111/j.1572-0241.2008.02175.x. Epub 2008 Oct 3.
7
Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials.肿瘤坏死因子拮抗剂治疗克罗恩病的疗效与安全性:安慰剂对照试验的荟萃分析
Clin Gastroenterol Hepatol. 2008 Jun;6(6):644-53. doi: 10.1016/j.cgh.2008.03.014.
8
Development and validation of the "Treatment Satisfaction with Medicines Questionnaire" (SATMED-Q).《药物治疗满意度问卷》(SATMED-Q)的编制与验证
Value Health. 2008 Sep-Oct;11(5):913-26. doi: 10.1111/j.1524-4733.2008.00323.x. Epub 2008 May 20.
9
Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.用于维持克罗恩病缓解的肿瘤坏死因子-α抗体。
Cochrane Database Syst Rev. 2008 Jan 23(1):CD006893. doi: 10.1002/14651858.CD006893.
10
Certolizumab pegol, a monthly subcutaneously administered Fc-free anti-TNFalpha, improves health-related quality of life in patients with moderate to severe Crohn's disease.赛妥珠单抗聚乙二醇,一种每月皮下注射的无Fc抗TNFα药物,可改善中重度克罗恩病患者与健康相关的生活质量。
Int J Colorectal Dis. 2008 Mar;23(3):289-96. doi: 10.1007/s00384-007-0395-7. Epub 2007 Dec 11.

评估克罗恩病患者对抗肿瘤坏死因子α治疗的满意度:一份新问卷开发的定性步骤

Assessing patients' satisfaction with anti-TNFα treatment in Crohn's disease: qualitative steps of the development of a new questionnaire.

作者信息

Marant Claire, Arnould Benoit, Marrel Alexia, Spizak Céderic, Colombel Jean-Frédéric, Faure Patrick, Hagege Hervé, Lemann Marc, Nahon Stéphane, Tucat Gilbert, Vandromme Luc, Thibout Emmanuel, Goldfarb Gérard

机构信息

Mapi Values, Patient-Reported Outcomes, 27 rue de la Villette, Lyon, France;

出版信息

Clin Exp Gastroenterol. 2011;4:173-80. doi: 10.2147/CEG.S18585. Epub 2011 Jul 27.

DOI:10.2147/CEG.S18585
PMID:21904463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3163923/
Abstract

PURPOSE

To develop a self-administered questionnaire assessing patients' satisfaction with treatments in Crohn's disease for use in clinical research and epidemiological studies.

PATIENTS AND METHODS

Semi-directive interviews (16) were conducted with patients with severe Crohn's disease treated with anti-tumor necrosis factor alpha (anti-TNFα). Transcripts were analyzed and concepts related to satisfaction with treatment were extracted and organized into a model. Items were generated using patients' words. The resulting test version was tested for relevance and comprehension with 7 patients and revised accordingly; the new version was tested with 5 other patients and revised to provide the pilot version. A clinician advisory board was involved at each milestone of the development.

RESULTS

The test questionnaire assessed treatment satisfaction through 67 items, organized into 5 sections: treatment efficacy, side-effects, convenience and constraints, overall impact, and satisfaction. Conceptual content of the questionnaire includes comparison with prior state and with expectations, satisfaction, acceptability, and intentions. The questionnaire was generally well accepted and understood by patients; few modifications were made in the structure and item formulation. After the second round of comprehension tests, the pilot version contained 62 items; the questionnaire was named Satisfaction of PAtients in Crohn's diseasE (SPACE(©)).

CONCLUSION

The questionnaire is a unique tool to assess treatment satisfaction in patients with Crohn's disease. A scoring and validation study is currently being performed to finalize and establish its scoring, as well as its psychometric properties.

摘要

目的

开发一份用于临床研究和流行病学研究的自我管理问卷,以评估克罗恩病患者对治疗的满意度。

患者与方法

对接受抗肿瘤坏死因子α(抗TNFα)治疗的重度克罗恩病患者进行了16次半指导性访谈。对访谈记录进行分析,提取与治疗满意度相关的概念并组织成一个模型。使用患者的原话生成问卷项目。将生成的测试版本与7名患者一起测试其相关性和可理解性,并据此进行修订;新版本再与另外5名患者一起测试,并再次修订以提供试点版本。在问卷开发的每个阶段都有一个临床顾问委员会参与。

结果

测试问卷通过67个项目评估治疗满意度,这些项目分为5个部分:治疗效果、副作用、便利性和限制、总体影响以及满意度。问卷的概念内容包括与先前状态和预期的比较、满意度、可接受性和意愿。该问卷总体上被患者很好地接受和理解;在结构和项目表述方面几乎没有修改。第二轮理解测试后,试点版本包含62个项目;该问卷被命名为克罗恩病患者满意度问卷(SPACE(©))。

结论

该问卷是评估克罗恩病患者治疗满意度的独特工具。目前正在进行一项评分和验证研究,以最终确定并建立其评分方法以及心理测量特性。